You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism

Article info

Article menu
XML
Basic tumor immunology
Original research
TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism

Authors

  • Stefania Canè Ludwig Institute for Cancer Research, De Duve Institute, Brussels, Belgiumde Duve Institute, UCLouvain, Brussels, BelgiumDepartment of Medicine, Immunology Section, University of Verona, Verona, Italy PubMed articlesGoogle scholar articles
  • Jacques Van Snick Ludwig Institute for Cancer Research, De Duve Institute, Brussels, Belgiumde Duve Institute, UCLouvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Catherine Uyttenhove Ludwig Institute for Cancer Research, De Duve Institute, Brussels, Belgiumde Duve Institute, UCLouvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Luc Pilotte Ludwig Institute for Cancer Research, De Duve Institute, Brussels, Belgiumde Duve Institute, UCLouvain, Brussels, BelgiumWELBIO, UCLouvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Benoit J Van den Eynde Ludwig Institute for Cancer Research, De Duve Institute, Brussels, Belgiumde Duve Institute, UCLouvain, Brussels, BelgiumWELBIO, UCLouvain, Brussels, Belgium PubMed articlesGoogle scholar articles

Citation

Canè S, Van Snick J, Uyttenhove C, et al
TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
Journal for ImmunoTherapy of Cancer 2021;9:e001798. doi: 10.1136/jitc-2020-001798
Online issue publication 
January 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.